Sonnet Biotherapeutics Holdings Stock Price History
SONN Stock | USD 1.36 0.04 2.86% |
Below is the normalized historical share price chart for Sonnet Biotherapeutics Holdings extending back to July 27, 2005. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Sonnet Biotherapeutics stands at 1.36, as last reported on the 27th of March, with the highest price reaching 1.41 and the lowest price hitting 1.33 during the day.
If you're considering investing in Sonnet Stock, it is important to understand the factors that can impact its price. Sonnet Biotherapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of close to zero, which indicates the firm had a close to zero % return per unit of risk over the last 3 months. Sonnet Biotherapeutics Holdings exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Sonnet Biotherapeutics' Risk Adjusted Performance of (0.02), variance of 31.81, and Coefficient Of Variation of (2,718) to confirm the risk estimate we provide.
At this time, Sonnet Biotherapeutics' Total Stockholder Equity is very stable compared to the past year. As of the 27th of March 2025, Stock Based Compensation To Revenue is likely to grow to 11.73, while Liabilities And Stockholders Equity is likely to drop about 28.3 M. . As of the 27th of March 2025, Price To Sales Ratio is likely to drop to 2.24. In addition to that, Price Earnings Ratio is likely to drop to -11.11. Sonnet Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 31st of October 2006 | 200 Day MA 4.4803 | 50 Day MA 1.5306 | Beta 1.01 |
Sonnet |
Sharpe Ratio = -0.004
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | SONN |
Estimated Market Risk
5.73 actual daily | 51 51% of assets are less volatile |
Expected Return
-0.02 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
0.0 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Sonnet Biotherapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Sonnet Biotherapeutics by adding Sonnet Biotherapeutics to a well-diversified portfolio.
Price Book 1.0101 | Enterprise Value Ebitda (0.21) | Price Sales 4.1694 | Shares Float 3 M | Wall Street Target Price 160 |
Sonnet Biotherapeutics Stock Price History Chart
There are several ways to analyze Sonnet Stock price data. The simplest method is using a basic Sonnet candlestick price chart, which shows Sonnet Biotherapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | January 22, 2025 | 2.0 |
Lowest Price | March 13, 2025 | 1.32 |
Sonnet Biotherapeutics March 27, 2025 Stock Price Synopsis
Various analyses of Sonnet Biotherapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Sonnet Stock. It can be used to describe the percentage change in the price of Sonnet Biotherapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Sonnet Stock.Sonnet Biotherapeutics Price Daily Balance Of Power | (0.50) | |
Sonnet Biotherapeutics Price Action Indicator | (0.03) | |
Sonnet Biotherapeutics Price Rate Of Daily Change | 0.97 |
Sonnet Biotherapeutics March 27, 2025 Stock Price Analysis
Sonnet Stock Price History Data
The price series of Sonnet Biotherapeutics for the period between Fri, Dec 27, 2024 and Thu, Mar 27, 2025 has a statistical range of 0.68 with a coefficient of variation of 8.79. The price distribution for the period has arithmetic mean of 1.55. The median price for the last 90 days is 1.54. The company completed stock split (1:8) on 30th of September 2024. Sonnet Biotherapeutics had dividends distributed to its stock-holders on 2020-04-02.Open | High | Low | Close | Volume | ||
03/27/2025 | 1.40 | 1.41 | 1.33 | 1.36 | ||
03/25/2025 | 1.40 | 1.41 | 1.33 | 1.36 | 20,880 | |
03/24/2025 | 1.39 | 1.42 | 1.34 | 1.40 | 31,408 | |
03/21/2025 | 1.36 | 1.42 | 1.33 | 1.38 | 66,899 | |
03/20/2025 | 1.37 | 1.46 | 1.35 | 1.43 | 19,398 | |
03/19/2025 | 1.39 | 1.47 | 1.35 | 1.40 | 122,701 | |
03/18/2025 | 1.38 | 1.39 | 1.33 | 1.39 | 14,581 | |
03/17/2025 | 1.35 | 1.39 | 1.34 | 1.39 | 29,474 | |
03/14/2025 | 1.39 | 1.39 | 1.30 | 1.36 | 11,444 | |
03/13/2025 | 1.39 | 1.43 | 1.32 | 1.32 | 29,711 | |
03/12/2025 | 1.40 | 1.41 | 1.35 | 1.39 | 13,536 | |
03/11/2025 | 1.43 | 1.43 | 1.35 | 1.39 | 16,243 | |
03/10/2025 | 1.51 | 1.52 | 1.40 | 1.40 | 44,507 | |
03/07/2025 | 1.49 | 1.50 | 1.44 | 1.49 | 27,484 | |
03/06/2025 | 1.43 | 1.48 | 1.43 | 1.44 | 15,090 | |
03/05/2025 | 1.39 | 1.54 | 1.38 | 1.46 | 42,489 | |
03/04/2025 | 1.47 | 1.50 | 1.30 | 1.45 | 111,741 | |
03/03/2025 | 1.52 | 1.55 | 1.50 | 1.51 | 26,201 | |
02/28/2025 | 1.51 | 1.55 | 1.48 | 1.55 | 29,661 | |
02/27/2025 | 1.50 | 1.55 | 1.50 | 1.54 | 29,360 | |
02/26/2025 | 1.51 | 1.57 | 1.46 | 1.52 | 82,883 | |
02/25/2025 | 1.51 | 1.53 | 1.44 | 1.50 | 24,723 | |
02/24/2025 | 1.41 | 1.55 | 1.39 | 1.51 | 115,858 | |
02/21/2025 | 1.44 | 1.46 | 1.38 | 1.44 | 67,880 | |
02/20/2025 | 1.50 | 1.50 | 1.41 | 1.43 | 54,116 | |
02/19/2025 | 1.50 | 1.53 | 1.38 | 1.50 | 426,082 | |
02/18/2025 | 1.59 | 1.59 | 1.50 | 1.53 | 39,810 | |
02/14/2025 | 1.57 | 1.60 | 1.54 | 1.59 | 47,430 | |
02/13/2025 | 1.51 | 1.55 | 1.51 | 1.54 | 31,398 | |
02/12/2025 | 1.57 | 1.60 | 1.50 | 1.56 | 69,202 | |
02/11/2025 | 1.58 | 1.64 | 1.55 | 1.57 | 101,919 | |
02/10/2025 | 1.62 | 1.66 | 1.55 | 1.59 | 43,990 | |
02/07/2025 | 1.58 | 1.62 | 1.55 | 1.59 | 47,503 | |
02/06/2025 | 1.65 | 1.69 | 1.61 | 1.62 | 32,310 | |
02/05/2025 | 1.60 | 1.67 | 1.57 | 1.64 | 49,475 | |
02/04/2025 | 1.57 | 1.65 | 1.55 | 1.62 | 44,930 | |
02/03/2025 | 1.60 | 1.64 | 1.53 | 1.59 | 50,333 | |
01/31/2025 | 1.72 | 1.75 | 1.62 | 1.65 | 55,780 | |
01/30/2025 | 1.69 | 1.75 | 1.67 | 1.73 | 49,290 | |
01/29/2025 | 1.69 | 1.87 | 1.66 | 1.69 | 73,080 | |
01/28/2025 | 1.81 | 1.91 | 1.64 | 1.73 | 224,354 | |
01/27/2025 | 1.81 | 1.93 | 1.73 | 1.81 | 146,168 | |
01/24/2025 | 1.70 | 1.93 | 1.70 | 1.83 | 316,668 | |
01/23/2025 | 1.79 | 1.85 | 1.64 | 1.71 | 384,300 | |
01/22/2025 | 1.58 | 2.05 | 1.53 | 2.00 | 1,084,350 | |
01/21/2025 | 1.49 | 1.56 | 1.44 | 1.54 | 452,030 | |
01/17/2025 | 1.55 | 1.57 | 1.50 | 1.54 | 67,088 | |
01/16/2025 | 1.52 | 1.58 | 1.50 | 1.54 | 73,244 | |
01/15/2025 | 1.53 | 1.58 | 1.46 | 1.52 | 63,660 | |
01/14/2025 | 1.60 | 1.60 | 1.50 | 1.52 | 108,745 | |
01/13/2025 | 1.60 | 1.60 | 1.53 | 1.58 | 117,118 | |
01/10/2025 | 1.59 | 1.61 | 1.51 | 1.58 | 111,614 | |
01/08/2025 | 1.76 | 1.76 | 1.51 | 1.55 | 281,016 | |
01/07/2025 | 1.94 | 1.99 | 1.72 | 1.78 | 321,855 | |
01/06/2025 | 1.75 | 2.52 | 1.75 | 1.90 | 1,668,903 | |
01/03/2025 | 1.60 | 1.80 | 1.60 | 1.75 | 323,962 | |
01/02/2025 | 1.46 | 1.73 | 1.46 | 1.60 | 290,471 | |
12/31/2024 | 1.50 | 1.54 | 1.45 | 1.46 | 145,352 | |
12/30/2024 | 1.51 | 1.53 | 1.45 | 1.48 | 94,927 | |
12/27/2024 | 1.51 | 1.54 | 1.44 | 1.51 | 157,738 | |
12/26/2024 | 1.45 | 1.52 | 1.43 | 1.49 | 280,945 |
About Sonnet Biotherapeutics Stock history
Sonnet Biotherapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Sonnet is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Sonnet Biotherapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Sonnet Biotherapeutics stock prices may prove useful in developing a viable investing in Sonnet Biotherapeutics
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 439.58 | 417.60 | |
Net Loss | -16.1 M | -16.9 M |
Sonnet Biotherapeutics Stock Technical Analysis
Sonnet Biotherapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Investing Opportunities Now
Investing OpportunitiesBuild portfolios using our predefined set of ideas and optimize them against your investing preferences |
All Next | Launch Module |
Sonnet Biotherapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Sonnet Biotherapeutics' price direction in advance. Along with the technical and fundamental analysis of Sonnet Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Sonnet to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.02) | |||
Jensen Alpha | (0.22) | |||
Total Risk Alpha | (0.20) | |||
Treynor Ratio | (0.24) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sonnet Biotherapeutics Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sonnet Biotherapeutics. If investors know Sonnet will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sonnet Biotherapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (10.22) | Revenue Per Share | Quarterly Revenue Growth 52.688 | Return On Assets | Return On Equity |
The market value of Sonnet Biotherapeutics is measured differently than its book value, which is the value of Sonnet that is recorded on the company's balance sheet. Investors also form their own opinion of Sonnet Biotherapeutics' value that differs from its market value or its book value, called intrinsic value, which is Sonnet Biotherapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sonnet Biotherapeutics' market value can be influenced by many factors that don't directly affect Sonnet Biotherapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sonnet Biotherapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Sonnet Biotherapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sonnet Biotherapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.